Myka Labs, developer of the revolutionary GlintTM smart catheter technology for treating serious conditions affecting the bowel, pancreas and other abdominal organs, today announced that it would exhibit at the upcoming American Pediatric Surgical Association (APSA) annual meeting.
At APSA, members of the Myka Labs team will offer hands-on demos with the company’s latest products and technology for endoscopic procedures, with advanced AI-powered functionality including visualization of hidden anatomy, real-time calculation of the extent of hollow organ dilation and other key parameters, and tool deployment assessment. By using Glint smart catheters and Myka’s accompanying AI-powered visualization environment, teams performing advanced endoscopic procedures can realize benefits including streamlined procedures, higher rates of achieving desired procedure outcomes, and expanded patient populations eligible for potentially life-saving endoscopic interventions.
Bringing to market high-clinical-impact solutions for conditions affecting pediatric patient populations is central to Myka Labs’ mission, with multiple pediatric products in the Myka Labs pipeline alongside products for conditions like pancreatic cancer. Myka Labs is commercializing Connect-EATM, a high-performance device system developed at UCSF Surgical Innovations for use by pediatric surgeons in repairing congenial malformations affecting the esophagus and windpipe. In publications appearing in leading journals, exceptionally favorable results have been reported for patients who have undergone Connect-EA procedures.
APSA will take place at the Fairmont Queen Elizabeth in Montreal, Canada from May 7-10, 2025.